Enfermedad renal crónica (ERC) is a growing global health concern, que afecta a millones de personas en todo el mundo. While the causes of CKD are diverse, a significant proportion of cases are attributed to infections. Recent breakthroughs in stem cell research offer promising new therapeutic options for patients with infection-driven CKD. This article explores the role of infection in CKD, el potencial de terapia con células madre, and the ongoing research in this field.
Infection-Driven Chronic Kidney Disease: A Growing Problem
Infections can lead to CKD through various mechanisms, including direct damage to kidney cells, inflamación, and immune-mediated responses. Bacterial, viral, and parasitic infections are common culprits, con infecciones del tracto urinario (UTIs) being a major risk factor for CKD. The prevalence of infection-driven CKD is particularly high in developing countries, where access to clean water and sanitation is limited.
Terapia con células madre: A Potential New Treatment Option
Terapia con células madre holds great promise as a potential treatment for infection-driven CKD. Las células madre tienen la capacidad de diferenciarse en varios tipos de células., incluyendo células renales. By transplanting stem cells into damaged kidneys, it may be possible to regenerate lost or damaged tissue and restore kidney function.
